With the use of the InProDel platform, SHIFTBIO developed HIF1α-NV, an innovation that enables the intracellular delivery of transcription factors to innate immune cells, thus potently enabling the regeneration of damaged organs.
With the use of the InProDel platform, SHIFTBIO developed HIF1α-NV, an innovation that enables the intracellular delivery of transcription factors to innate immune cells, thus potently enabling the regeneration of damaged organs.
